Cyclosporin A (CSA) is an immunosuppressive agent that has provided ne
w approaches in transplantation medicine and in the treatment of autoi
mmune diseases. One of the most common dermatological side effects of
oral CSA is dose-dependent hypertrichosis. This stimulating effect on
hair growth encouraged a number of investigators to use CSA not only i
n the treatment of alopecia areata (AA), but also in male pattern alop
ecia (MPA). While oral application proved successful, the beneficial e
ffect of topical application was very limited in both AA and MPA.